{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:15:48Z","timestamp":1787199348770,"version":"build-2736575974"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":89,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.jtauto.2022.100154","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T21:36:32Z","timestamp":1649799392000},"page":"100154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases"],"prefix":"10.1016","volume":"5","author":[{"given":"Regina","family":"Larionova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Byvaltsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u041elga","family":"Kravtsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Takha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gevorg","family":"Kazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Valeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Shuralev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Mukminov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Renaudineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Arleevskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2022.100154_bib1","doi-asserted-by":"crossref","first-page":"666223","DOI":"10.3389\/fimmu.2021.666223","article-title":"Profile of circulatory cytokines and chemokines in human coronaviruses: a systematic review and meta-analysis","volume":"12","author":"Zawawi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","article-title":"COVID-19, SARS and MERS: are they closely related?","volume":"26","author":"Petrosillo","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jtauto.2022.100154_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.25709","article-title":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS\u2010CoV, MERS\u2010CoV, and 2019\u2010nCoV","volume":"92","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib4","doi-asserted-by":"crossref","first-page":"552909","DOI":"10.3389\/fimmu.2020.552909","article-title":"Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses","volume":"11","author":"Abdelrahman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.immuni.2020.07.005","article-title":"Lessons for COVID-19 immunity from other coronavirus infections","volume":"53","author":"Sariol","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2022.100154_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jtauto.2022.100154_bib7","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2022.100154_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jtauto.2022.100154_bib9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtauto.2022.100154_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.jtauto.2022.100154_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2022.100154_bib12","doi-asserted-by":"crossref","first-page":"108410","DOI":"10.1016\/j.clim.2020.108410","article-title":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients","volume":"215","author":"Sawalha","year":"2020","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2022.100154_bib13","doi-asserted-by":"crossref","first-page":"108937","DOI":"10.1016\/j.clim.2022.108937","article-title":"Long non-coding RNA Xist contribution in systemic lupus erythematosus and rheumatoid arthritis","volume":"236","author":"Bost","year":"2022","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2022.100154_bib14","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1093\/rheumatology\/keaa898","article-title":"Decreased serum ACE2 levels in patients with connective tissue diseases","volume":"60","author":"Tang","year":"2021","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jtauto.2022.100154_bib15","first-page":"8","article-title":"Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients","volume":"115","author":"Fagyas","year":"2022","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib16","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar3012","article-title":"Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases","volume":"12","author":"Takahashi","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2022.100154_bib17","doi-asserted-by":"crossref","first-page":"641295","DOI":"10.3389\/fimmu.2021.641295","article-title":"Anti-TNF-\u03b1 agents modulate SARS-CoV-2 receptors and increase the risk of infection through notch-1 signaling","volume":"12","author":"Keewan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib18","doi-asserted-by":"crossref","first-page":"106749","DOI":"10.1016\/j.intimp.2020.106749","article-title":"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19","volume":"86","author":"Zhang","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.jtauto.2022.100154_bib19","doi-asserted-by":"crossref","first-page":"1690.e1","DOI":"10.1016\/j.cmi.2020.08.043","article-title":"The kinetics of viral load and antibodies to SARS-CoV-2","volume":"26","author":"Sun","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jtauto.2022.100154_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017962118","article-title":"Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort","volume":"118","author":"N\u00e9ant","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jtauto.2022.100154_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1515\/med-2021-0283","article-title":"Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB","volume":"16","author":"Li","year":"2021","journal-title":"Open Med."},{"key":"10.1016\/j.jtauto.2022.100154_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41420-020-00375-y","article-title":"Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity","volume":"6","author":"Agarwal","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jmv.25825","article-title":"The presence of SARS\u2010CoV\u20102 RNA in the feces of COVID\u201019 patients","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib24","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.200623","article-title":"A convalescent of COVID-19 with RT-PCR test continues positive in stool","volume":"66","author":"Yang","year":"2020","journal-title":"Clin. Lab."},{"key":"10.1016\/j.jtauto.2022.100154_bib25","first-page":"936","article-title":"SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient","volume":"27","author":"Rizzo","year":"2021","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/gutjnl-2021-324622","article-title":"Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19","volume":"70","author":"Neurath","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2022.100154_bib27","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jtauto.2022.100154_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12026-020-09137-5","article-title":"Covid 19: a clue from innate immunity","volume":"68","author":"Birra","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jtauto.2022.100154_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.jtauto.2022.100154_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.immuni.2020.07.005","article-title":"Lessons for COVID-19 immunity from other coronavirus infections","volume":"53","author":"Sariol","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2022.100154_bib31","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","author":"Manik","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib32","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/jmv.27050","article-title":"SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways","volume":"93","author":"Han","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2022.100154_bib34","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jtauto.2022.100154_bib142","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-019-08742-z","article-title":"Toll-like receptors, infections, and rheumatoid arthritis","volume":"58","author":"Arleevskaya","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib35","article-title":"Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus","author":"Gupta","year":"2020","journal-title":"MedRxiv Prepr. Serv. Health Sci."},{"key":"10.1016\/j.jtauto.2022.100154_bib36","doi-asserted-by":"crossref","first-page":"100090","DOI":"10.1016\/j.jtauto.2021.100090","article-title":"An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases","volume":"4","author":"Bettacchioli","year":"2021","journal-title":"J. Transl. Autoimmun."},{"issue":"6","key":"10.1016\/j.jtauto.2022.100154_bib143","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.jtauto.2022.100154_bib144","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/art.41697","article-title":"A proinflammatory cytokine network profile in Th1\/type 1 effector B cells delineates a common group of patients in four systemic autoimmune diseases","volume":"73","author":"Simon","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib37","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/art.30399","article-title":"Association of endogenous anti-interferon-\u03b1 autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus","volume":"63","author":"Morimoto","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2022.100154_bib38","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/art.39607","article-title":"Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases","volume":"68","author":"Gupta","year":"2016","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.jtauto.2022.100154_bib39","doi-asserted-by":"crossref","first-page":"155633","DOI":"10.1016\/j.cyto.2021.155633","article-title":"Abnormalities of the type I interferon signaling pathway in lupus autoimmunity","volume":"146","author":"Gallucci","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jtauto.2022.100154_bib40","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI127101","article-title":"A promising approach to targeting type 1 IFN in systemic lupus erythematosus","volume":"129","author":"Chaichian","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtauto.2022.100154_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2022.100154_bib42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/eji.202149361","article-title":"Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells","volume":"52","author":"Cenac","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-020-02177-0","article-title":"The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis","volume":"22","author":"Wilkinson","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2022.100154_bib44","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1177\/0961203320959702","article-title":"Biologics targeting type I interferons in SLE: a meta-analysis and systematic review of randomised controlled trials","volume":"29","author":"Koh","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2022.100154_bib45","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3389\/fimmu.2020.02063","article-title":"Excessive neutrophils and neutrophil extracellular traps in COVID-19","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib46","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jiaa387","article-title":"Definition and risks of cytokine release syndrome in 11 critically ill COVID-19 patients with pneumonia: analysis of disease characteristics","volume":"222","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib47","doi-asserted-by":"crossref","first-page":"661052","DOI":"10.3389\/fimmu.2021.661052","article-title":"SARS-CoV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib48","doi-asserted-by":"crossref","first-page":"155507","DOI":"10.1016\/j.cyto.2021.155507","article-title":"IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19","volume":"143","author":"Luporini","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jtauto.2022.100154_bib49","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtauto.2022.100154_bib50","doi-asserted-by":"crossref","DOI":"10.2196\/20193","article-title":"Hazards of the cytokine storm and cytokine-targeted therapy in patients with COVID-19: review","volume":"22","author":"Quirch","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.jtauto.2022.100154_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2021.1995860","article-title":"The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease","volume":"55","author":"Kong","year":"2022","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2022.100154_bib52","doi-asserted-by":"crossref","first-page":"110542","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.jtauto.2022.100154_bib53","doi-asserted-by":"crossref","first-page":"627914","DOI":"10.3389\/fcell.2021.627914","article-title":"PNPLA3 and TLL-1 polymorphisms as potential predictors of disease severity in patients with COVID-19","volume":"9","author":"Grimaudo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jtauto.2022.100154_bib54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1469-0691.2004.01009.x","article-title":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus","volume":"10","author":"Hsueh","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jtauto.2022.100154_bib55","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2021.12.014","article-title":"Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: real-world data from a large cohort of healthcare workers","volume":"40","author":"Oliveira-Silva","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jtauto.2022.100154_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","article-title":"A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity","volume":"18","author":"Legros","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib57","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib58","first-page":"2785","article-title":"Cutting edge: distinct B cell repertoires characterize patients with mild and severe COVID-19","volume":"206","author":"Hoehn","year":"2021","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.jtauto.2022.100154_bib59","series-title":"The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19","author":"Kaneko","year":"2020"},{"key":"10.1016\/j.jtauto.2022.100154_bib60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.autrev.2006.02.004","article-title":"Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy","volume":"5","author":"Martinez-Gamboa","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2022.100154_bib61","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137799","article-title":"The laboratory tests and host immunity of COVID-19 patients with different severity of illness","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtauto.2022.100154_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-020-00308-2","article-title":"Storm of soluble immune checkpoints associated with disease severity of COVID-19","volume":"5","author":"Kong","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jtauto.2022.100154_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib64","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib65","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1128\/JVI.05039-11","article-title":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope","volume":"85","author":"Oh","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib66","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108979","article-title":"Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response","volume":"237","author":"Renaudineau","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib67","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jtauto.2022.100154_bib68","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4 + T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib69","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib70","doi-asserted-by":"crossref","first-page":"102682","DOI":"10.1016\/j.jaut.2021.102682","article-title":"Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals","volume":"122","author":"Lingel","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2022.100154_bib71","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2022.100154_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001580","article-title":"Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review","volume":"7","author":"Taha","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.jtauto.2022.100154_bib73","doi-asserted-by":"crossref","first-page":"584241","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-Phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib74","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1055\/s-0037-1613055","article-title":"Distinguishing features of anti-beta 2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome","volume":"87","author":"Arvieux","year":"2002","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.jtauto.2022.100154_bib75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clim.2019.06.002","article-title":"News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination","volume":"205","author":"Bettacchioli","year":"2019","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2022.100154_bib76","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.jtauto.2020.100073","article-title":"Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19)","volume":"3","author":"Lerma","year":"2020","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2022.100154_bib77","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","article-title":"High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia","volume":"39","author":"Gazzaruso","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib78","doi-asserted-by":"crossref","first-page":"100091","DOI":"10.1016\/j.jtauto.2021.100091","article-title":"Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19","volume":"4","author":"Anaya","year":"2021","journal-title":"J. Transl. Autoimmun."},{"issue":"1","key":"10.1016\/j.jtauto.2022.100154_bib139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08916930400022574","article-title":"Rheumatoid factor on a daily basis","volume":"38","author":"Renaudineau","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2022.100154_bib79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15321819.2016.1174136","article-title":"ANA testing in the presence of acute and chronic infections","volume":"37","author":"Litwin","year":"2016","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.jtauto.2022.100154_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/1744666X.1.2.213","article-title":"Natural autoantibodies: immune homeostasis and therapeutic intervention","volume":"1","author":"Bayry","year":"2005","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib81","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3389\/fmicb.2016.01296","article-title":"How rheumatoid arthritis can result from provocation of the immune system by microorganisms and viruses","volume":"7","author":"Arleevskaya","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jtauto.2022.100154_bib82","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic purpura in a patient with covid-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2022.100154_bib83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00296-021-04794-7","article-title":"Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review","volume":"41","author":"Gracia-Ramos","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jtauto.2022.100154_bib84","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/1756-185X.14220","article-title":"Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection","volume":"24","author":"Baimukhamedov","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib85","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib86","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.3390\/antib9030033","article-title":"From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry","volume":"9","author":"Kanduc","year":"2020","journal-title":"Antibodies Basel Switz"},{"key":"10.1016\/j.jtauto.2022.100154_bib87","doi-asserted-by":"crossref","first-page":"103012","DOI":"10.1016\/j.autrev.2021.103012","article-title":"Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden Symposium on Autoantibodies","volume":"21","author":"Damoiseaux","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2022.100154_bib88","doi-asserted-by":"crossref","first-page":"E4662","DOI":"10.3390\/ijms21134662","article-title":"Putative roles for peptidylarginine deiminases in COVID-19","volume":"21","author":"Arisan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2022.100154_bib89","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.40066","article-title":"Anti-citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients","volume":"69","author":"Demoruelle","year":"2017","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.jtauto.2022.100154_bib90","first-page":"138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtauto.2022.100154_bib91","doi-asserted-by":"crossref","first-page":"600881","DOI":"10.3389\/fmolb.2021.600881","article-title":"Circulating nucleosomes as potential markers to monitor COVID-19 disease progression","volume":"8","author":"Cavalier","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jtauto.2022.100154_bib92","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2665-9913(20)30396-9","article-title":"First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection","volume":"3","author":"Perrot","year":"2021","journal-title":"Lanc. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-220010","article-title":"Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study","author":"Mageau","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib94","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1177\/09612033211045057","article-title":"COVID-19 in systemic lupus erythematosus: a pooled analysis and systematic review of case reports and series","volume":"30","author":"Sakthiswary","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2022.100154_bib95","article-title":"Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak","author":"Holubar","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245274","article-title":"Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: weighting the risk of infection and flare","volume":"16","author":"Zucchi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2022.100154_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054753","article-title":"Association between previous rheumatoid arthritis and COVID-19 and its severity: a nationwide cohort study in South Korea","volume":"11","author":"Jung","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtauto.2022.100154_bib98","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2665-9913(21)00112-0","article-title":"SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study","volume":"3","author":"Saadoun","year":"2021","journal-title":"Lanc. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib99","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib100","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","author":"Akiyama","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib101","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/annrheumdis-2021-220418","article-title":"Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry","volume":"80","author":"Sparks","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s42358-021-00217-0","article-title":"Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil","volume":"61","author":"Pileggi","year":"2021","journal-title":"Adv. Rheumatol. Lond. Engl."},{"key":"10.1016\/j.jtauto.2022.100154_bib103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2022.100154_bib104","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1038\/s41598-021-84153-5","article-title":"Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization","volume":"11","author":"Joo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2022.100154_bib105","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.55563\/clinexprheumatol\/fmkp4b","article-title":"Association of influenza infection with hospitalisation-related systemic lupus erythematosus flares: a time series analysis","volume":"39","author":"Joo","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib107","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2474-13-158","article-title":"Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study","volume":"13","author":"Blumentals","year":"2012","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.jtauto.2022.100154_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2019.01.004","article-title":"In seroconverted rheumatoid arthritis patients a multi-reactive anti-herpes IgM profile is associated with disease activity","volume":"200","author":"Larionova","year":"2019","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2022.100154_bib109","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3389\/fimmu.2017.01725","article-title":"Associations between viral infection history symptoms, granulocyte reactive oxygen species activity, and active rheumatoid arthritis disease in untreated women at onset: results from a longitudinal cohort study of tatarstan women","volume":"8","author":"Arleevskaya","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib110","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3389\/fimmu.2018.02771","article-title":"Prevalence and incidence of upper respiratory tract infection events are elevated prior to the development of rheumatoid arthritis in first-degree relatives","volume":"9","author":"Arleevskaya","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib111","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/09612033211002270","article-title":"Systemic lupus erythematosus and COVID-19 during pregnancy","volume":"30","author":"Smeele","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2022.100154_bib112","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.41937","article-title":"Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS-CoV-2 vaccination","volume":"74","author":"Izmirly","year":"2022","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.jtauto.2022.100154_bib113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-021-02674-w","article-title":"Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine","volume":"24","author":"Spinelli","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2022.100154_bib114","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.3390\/ijms22168965","article-title":"Adaptive immunity and the risk of autoreactivity in COVID-19","volume":"22","author":"Moody","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2022.100154_bib115","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","author":"Chen","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.jtauto.2022.100154_bib116","doi-asserted-by":"crossref","first-page":"101585","DOI":"10.1016\/j.bjid.2021.101585","article-title":"Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: a case report","volume":"25","author":"Crivelenti","year":"2021","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13256-020-02582-8","article-title":"Systemic lupus erythematosus manifestation following COVID-19: a case report","volume":"15","author":"Zamani","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jtauto.2022.100154_bib118","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jmv.26513","article-title":"Systemic lupus erythematosus and varicella\u2010like rash following COVID\u201019 in a previously healthy patient","volume":"93","author":"Slimani","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jtauto.2022.100154_bib119","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","article-title":"Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology","volume":"39","author":"Mantovani Cardoso","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib120","doi-asserted-by":"crossref","first-page":"645013","DOI":"10.3389\/fimmu.2021.645013","article-title":"Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib121","first-page":"9695","article-title":"The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection","volume":"24","author":"Bonometti","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jtauto.2022.100154_bib122","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218315","article-title":"Comparative analysis of synovial inflammation after SARS-CoV-2 infection","volume":"80","author":"Alivernini","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib123","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1016\/S2665-9913(20)30216-2","article-title":"Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection","volume":"2","author":"Talarico","year":"2020","journal-title":"Lanc. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib124","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/annrheumdis-2021-219859","article-title":"Onset of rheumatoid arthritis after COVID-19: coincidence or connected?","volume":"80","author":"Derksen","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2022.100154_bib125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-019-1977-9","article-title":"Respiratory viral infections and the risk of rheumatoid arthritis","volume":"21","author":"Joo","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2022.100154_bib126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtauto.2022.100154_bib127","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jtauto.2022.100154_bib128","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jtauto.2022.100154_bib129","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/ATVBAHA.120.315267","article-title":"Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19","volume":"41","author":"Ng","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jtauto.2022.100154_bib130","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3390\/biomedicines9121867","article-title":"PAD inhibitors as a potential treatment for SARS-CoV-2 immunothrombosis","volume":"9","author":"Elliott","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtauto.2022.100154_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jtauto.2022.100154_bib132","doi-asserted-by":"crossref","first-page":"785355","DOI":"10.3389\/fimmu.2021.785355","article-title":"Innate receptors expression by lung nociceptors: impact on COVID-19 and aging","volume":"12","author":"Hiroki","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100154_bib133","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1148\/radiol.2373041919","article-title":"Radiographic-clinical correlation in severe acute respiratory syndrome: study of 1373 patients in Hong Kong","volume":"237","author":"Antonio","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jtauto.2022.100154_bib134","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/bmj.326.7403.1354","article-title":"Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study","volume":"326","author":"Rainer","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jtauto.2022.100154_bib135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11239-020-02289-z","article-title":"Coronavirus disease 2019 (COVID-19) in patients with systemic autoimmune diseases or vasculitis: radiologic presentation","volume":"51","author":"Eslambolchi","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jtauto.2022.100154_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2021.12.028","article-title":"Surgically treated reactive arthritis of the ankle after COVID-19 infection: a case report","author":"Shimoyama","year":"2022","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc. Chemother."},{"key":"10.1016\/j.jtauto.2022.100154_bib137","article-title":"A case of SARS-CoV-2-associated arthritis with detection of viral RNA in synovial fluid","volume":"2","author":"Kuschner","year":"2021","journal-title":"J. Am. Coll. Emerg. Physicians Open"},{"key":"10.1016\/j.jtauto.2022.100154_bib138","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00393-021-01045-9","article-title":"[Post-Corona-Virus-Disease-19 arthritis. Manifestation under the clinical picture of a reactive arthritis]","volume":"80","author":"Zeidler","year":"2021","journal-title":"Z. Rheumatol."},{"key":"10.1016\/j.jtauto.2022.100154_bib140","article-title":"Causal risk and protective factors in rheumatoid arthritis: A genetic update","volume":"4","author":"Arleevskaya","year":"2021","journal-title":"Transl. Autoimmun."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909022000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909022000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:33:42Z","timestamp":1762904022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909022000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":144,"alternative-id":["S2589909022000156"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2022.100154","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2022.100154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100154"}}